QR-Code

Current status of pharmacotherapy for primary sclerosing cholangitis

Primary sclerosing cholangitis (PSC) represents a cholestatic disease hallmarked by persistent and progressive inflammation of the bile ducts. Despite its low incidence and unfavorable prognosis, there is no pharmacological therapy capable of altering the course of PSC, and liver transplantation is...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Hang Yang, Juan Zhen, Xiaoyan Huang, Minqi Chen, Hongsi Cui, Xia Sheng, Xinyu Li
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2025-06-01
Schriftenreihe:Frontiers in Medicine
Schlagworte:
primary sclerosing cholangitis
ursodeoxycholic acid
Nor-UDCA
clinical trial
drug therapy
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fmed.2025.1544601/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge